Effect of rosuvastatin on methionine-induced hyperhomocysteinaemia and haematological changes in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 3, 2008, Pages 287-292

  Nigam, Gaurav Kumar ^a   Ansari, M Nazam ^a   Bhandari, Uma ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE; ROSUVASTATIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEMATOLOGICAL PARAMETERS; HYPERHOMOCYSTEINEMIA; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; FLUOROBENZENES; HEMATOLOGIC TESTS; HEMOGLOBINS; HYPERHOMOCYSTEINEMIA; LEUKOCYTE COUNT; MALE; METHIONINE; PLATELET COUNT; PYRIMIDINES; RATS; RATS, WISTAR; SULFONAMIDES; TRIGLYCERIDES;

RATTUS;

EID: 49849100309     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00293.x     Document Type: Article

References (33)

1. Woo CWH, Siow YL, Pierce GN, Choy PC, Minuk GY, Mumin D, O K. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am J Physiol Endocrinol Metab 2005 288 : E1002 10.
2. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Eng J Med 1991 324 : 1149 55.
3. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004 11 : S56 S64.
4. Jocelyn PC. Biochemistry of the SH Group: The Occurrence, Chemical Properties, Metabolism and Biological Function of Thiols and Disulphides. Academic press, New York, 1984 84 115.
5. Hennig B, Toborek M, Alvarado Cader A, Decker E. Nutrition, endothelial cell metabolism, and atherosclerosis. Crit Rev Food Sci Nutr 1993 34 : 253 82.
6. Klavins JV, Kinney TD. Histopathologic changes in methionine excess. Arch Pathol 1963 75 : 661 73.
7. Benevenga NJ, Steele RD. Adverse effects of excessive consumption of amino acids. Annu Rev Nutr 1984 4 : 157 81.
8. Bath PM, Gladwin AM, Martin JF. Human monocyte characteristics are altered in hypercholesterolemia. Atherosclerosis 1991 90 : 175 81.
9. Rasouli M, Kiasari AM, Bagheri B. Total and differential leukocytes counts, but not hsCRP, ESR, and five fractioned serum proteins have significant potency to predict stable coronary artery disease. Clin Chim Acta 2007 377 : 127 32.
10. Durand P, Lussiercacan CS, Biache D. Acute methionine load-induced Hhcy enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 1997 11 : 1157 68.
11. Bickel C, Rupprecht HJ, Rippin G, Hafner G, Treude R, Othman H et al. Relation of markers of inflammation and statin therapy to long term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002 89 : 901 8.
12. Millionis HJ, Elisaf MS. Comparative effects of atorvastatin, simvastatin and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. J Clin Pharmacol 2003 43 : 825 30.
13. Stalker IJ, Lefer AM, Scalia R. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol 2001 133 : 406 12.
14. Ikeda Y, Young LH, Lefer AM. Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic repurfused myocardium in normocholesterolemic rats. J Cardiovasc Pharmacol 2003 41 : 649 56.
15. Yen CH, Lau YT. Vascular responses in male and female hypertensive rats with hyperhomocysteinemia. Hypertension 2002 40 : 322.
16. Primus FJ, Kelley EA, Hansen HJ, Goldenberg DM. Sandwich-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy. Clin Chem 1988 34 : 261 4.
17. Burstein M, Scholnick MR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970 11 : 583 6.
18. Demacher PNM, Hijamaus AGM. A study of the use of polyethylene glycol in estimating cholesterol. Clin Chem 1980 26 : 1775 8.
19. Foster LB, Dunn RT. Stable reagents for the determination of serum triglycerides by a colorimetric Hantzch condensation method. Clin Chem 1973 19 : 338 40.
20. Stein JH, McBride PE. Hyperhomocystenemia and atherosclerotic vascular disease: pathophysiology, screening and treatment. Arch Intern Med 1998 158 : 1301 6.
21. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 1969 22 : 215 7.
22. Delanty N, Vaughan CJ. Vascular effects of statins in stroke. Stroke 1997 28 : 2315 20.
23. Halcox JP, Deanfield JE. Beyond the laboratory: clinical implications for statin pleiotropy. Circulation 2004 109 (Suppl. 1 1141 8.
24. Laufs U, Gertz K, Dirnagl U, Bohm M, Nickenig G, Endres M. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 2002 942 : 23 30.
25. Jones SP, Gibson MF, Rimmer III DM, Gibson TM, Sharp BR, Lefer DJ. Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor. J Am Coll Cardiol 2002 40 : 1172 8.
26. Kleenmann R, Princen HM, Emeis JJ, Jukema JW, Fonijn RD, Horrevoets AJ. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for anti-inflammatory effects of rosuvastatin. Circulation 2003 108 : 1368 74.
27. Monetti M, Canavesi M, Camera M, Parente R, Paoletti R, Tremoli E et al. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice. Pharmacol Res 2007 55 : 441 9.
28. Kapoor HK, Bhai S, John M, Xavier J. Ocular manifestations of dengue fever in an East Indian epidemic. Can J Ophthalmol 2006 41 : 741 6.
29. Zulli A, Buxton B, Doolan L, Liu JJ. Effect of homocysteine and cholesterol in raising plasma homocysteine, cholesterol and triglyceride levels. Life Sci 1998 62 : 2191 4.
30. Nicholas PB, Dubman T, Guo XW. Homocysteine enhances neutrophil- endothelial interactions in both cultured human cells and rats in vivo. Circ Res 1999 84 : 409 416.
31. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986 314 : 488 500.
32. Suzuki M, O'Neal RM. Circulating lipophages, serum lipids, and atherosclerosis in rats. Arch Pathol 1967 83 : 169 74.
33. Suzuki M, O'Neal RM. Accumulation of lipids in the leukocytes of rats fed atherogenic diets. J Lipid Res 1964 5 : 624 7.